Antimetabolites: all 7,305 studies that test it
Page 42 of 74. Open to participants first (1,098), then studies with results posted, then the rest; newest registration first within each.
- Apatinib Combined With Capecitabine Compared With Apatinib Treat Advanced Hepatocellular CarcinomaStatus unknownNCT03114085Phase 2
- FOLFIRI as Salvage Treatment in Metastatic Biliary Tract Cancer (BTC) Patients Who Were Failed After Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective StudyWithdrawnNCT03110510Phase 2
- Pemetrexed in Combination With Erlotinib as a Salvage Treatment in Patients With Metastatic Biliary Tract Cancer (BTC) Who Failed Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective StudyStatus unknownNCT03110484Phase 2
- Beneficial and Harmful Effects of Azathioprine and Allopurinol Versus Standard Azathioprine Therapy for Patients With Ulcerative ColitisStatus unknownNCT03101800Phase 3
- Intrathecal Pemetrexed for Recurrent Leptomeningeal Metastases From Non-small Cell Lung CancerCompletedNCT03101579Phase 1
- Comparison of Mycophenolate Mofetil and Cyclophosphamide for Active Takayasu's ArteritisCompletedNCT03096275Phase 3
- A Study of Apatinib Plus Tegafur Gimeracil Oteracil in Recurrent/Metastatic Head and Neck CancersStatus unknownNCT03096184Phase 2
- A Study of Two Dosing Schedules of Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment for Metastatic Bladder CancerCompletedNCT03093922Phase 2
- BCMA Chimeric Antigen Receptor Expressing T Cells in Multiple MyelomaStatus unknownNCT03093168Phase 1
- Pemetrexed Plus Tarceva as Salvage Treatment in EGFR Overexpressed Metastatic Colorectal Cancer Patients Who Were Failed After Standard ChemotherapyCompletedNCT03086538Phase 2
- Raltitrexed and Paclitaxel for Gastric or Gastroesophageal Junction AdenocarcinomaCompletedNCT03083613Phase 2
- Concurrent Involved-field Radiotherapy and Intrathecal Chemotherapy for Leptomeningeal Metastases From Solid TumorsCompletedNCT03082144Phase 2
- Pyrotinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer. (PHOEBE)Status unknownNCT03080805Phase 3
- The Use of Decitabine as Induction Therapy for Acute Myeloid Leukemia With Complex and/or Monosomal KaryotypeStatus unknownNCT03080766Phase 2
- Adjuvant Capecitabine vs Gemcitabine Plus Cisplatin in Resected Extrahepatic CholangiocarcinomaCompletedNCT03079427Phase 2
- Gender Differences in the Metabolic Effects of Uric AcidWithdrawnNCT03076684Early Phase 1
- Combination Chemotherapy Including Cisplatin, Ifosfamide, Gemcitabine, L-asparaginase, Etoposide and Dexamethasone as Treatment of Newly Diagnosed and Relapsed/Refractory Peripheral T Cell LymphomasStatus unknownNCT03071822Phase 4
- FOLFIRI Versus Docetaxel and Cisplatin as a Second-line Chemotherapy After Failure of First-line Chemotherapy in Advanced Gastric CancerCompletedNCT03067792Phase 3
- Study of PDR001 and/or MBG453 in Combination With Decitabine in Patients With AML or High Risk MDSCompletedNCT03066648Phase 1
- Clinical Trial Evaluating Metronomic Chemotherapy in Patients With Metastatic OsteosarcomaStatus unknownNCT03063983Phase 2
- STAT Inhibitor OPB-111077, Decitabine and Venetoclax in Treating Patients With Acute Myeloid Leukemia That Is Refractory, Relapsed or Newly Diagnosed and Ineligible for Intensive ChemotherapyCompletedNCT03063944Phase 1
- Hydroxyurea in the Emergency Room to Lessen Pain in Sickle Cell CrisisStatus unknownNCT03062501Phase 2
- Mineralocorticoid Receptor, NMDA Receptor and Cognitive Function in DepressionCompletedNCT03062150Not applicable
- A Prospective Study of Neoadjuvant Chemotherapy With Gemcitabine/Platinum in Muscle-Invasive or Locally-Advanced Urothelial Carcinoma of BladderStatus unknownNCT03061630Phase 2
- Individualized Intraperitoneal and System Chemotherapy Versus System Chemotherapy as First-line Chemotherapy for AGCStatus unknownNCT03061058Phase 3
- Efficacy of Starting Methotrexate Early in Chikungunya ArthritisCompletedNCT03058471Not applicable
- Irinotecan Plus Raltitrexed as Second-line Treatment in Advanced Colorectal Cancer PatientsStatus unknownNCT03053167Phase 2
- Copanlisib and Gemcitabine in Relapsed/Refractory PTCLCompletedNCT03052933Phase 1/2
- Phase 2 Trial of Nab-paclitaxel Plus S-1 vs Gemcitabine Plus Cisplatin as 1-line Chemotherapy of Patients With Local Advanced and/or Metastatic Transitional Cell Carcinoma of Urothelial TractCompletedNCT03051373Phase 2
- Durvalumab(MEDI4736)/Tremelimumab in Combination With Gemcitabine/Cisplatin in Chemotherapy-naïve Biliary Tract CancerActive, not recruitingNCT03046862Phase 2
- Efficacy and Safety of Ultra Small Dose Decitabine for the Lower Risk MDS Patients With Transfusion DependentStatus unknownNCT03045510Phase 2
- PD-1 Knockout EBV-CTLs for Advanced Stage Epstein-Barr Virus (EBV) Associated MalignanciesStatus unknownNCT03044743Phase 1/2
- Multicenter, Prospective, RCT：Investigation of Combined Modality Therapy for Locally Advanced Mid/Low Rectal Cancer.Status unknownNCT03042000Not applicable
- Testing a New Chemotherapy Drug, KRT-232 (AMG-232) in Combination With Decitabine and Venetoclax in Patients With Acute Myeloid LeukemiaActive, not recruitingNCT03041688Phase 1
- Investigation of the Value of ctDNA in Diagnosis, Treatment, and Surveillance of Surgically Resectable Colorectal CancerStatus unknownNCT03038217Phase 3
- Outpatient Performed Pterygium Surgery StudyWithdrawnNCT03037736Phase 4
- Alitretinoin vs Azathioprine in Severe Non-hyperkeratotic Hand EczemaStatus unknownNCT03026907Phase 3
- Decitabine Versus Conventional Chemotherapy for Maintenance Therapy of Acute Myeloid Leukemia With t(8;21)Status unknownNCT03026842Phase 4
- Cytoreductive Surgery Combined With HIPEC and Chemotherapy for Gastric Cancer With Peritoneal MetastasisStatus unknownNCT03023436Phase 3
- Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid TumorsCompletedNCT03023319Phase 1
- Optimizing 6-mercaptopurine Therapy in Pediatric Acute Lymphoblastic Leukemia by Using AllopurinolStatus unknownNCT03022747Phase 2
- Efficacy of Decitabine in Clearance of MRDWithdrawnNCT03021395Phase 1/2
- Efficacy of Intermediate-Dose Cytarabine Induction Regimen in Adult AMLActive, not recruitingNCT03021330Phase 3
- Induction Chemotherapy in Young Patients With Locoregionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT03020329Phase 2
- Paediatric Hepatic International Tumour TrialActive, not recruitingNCT03017326Phase 3
- Genetically Modified T Cells and Decitabine in Treating Patients With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube CancerActive, not recruitingNCT03017131Phase 1
- The Efficacy and Safety of Bortezomib Combined With Fludarabine and Cytarabine Treatment for Mantle Cell LymphomaStatus unknownNCT03016988Phase 2
- Sequential Neo-adjuvant Chemotherapy Followed by Capecitabine Vs. Conventional Adjuvant Chemotherapy in Breast CancerStatus unknownNCT03011060Phase 3
- Pevonedistat and Decitabine in Treating Patients With High Risk Acute Myeloid LeukemiaCompletedNCT03009240Phase 1
- PERS Genetic Model Assistant Decision-making System of Neoadjuvant Chemotherapy for Breast CancerStatus unknownNCT03006614Phase 3
- Mirvetuximab Soravtansine and Gemcitabine Hydrochloride in Treating Patients With FRalpha-Positive Recurrent Ovarian, Primary Peritoneal, Fallopian Tube, Endometrial, or Triple Negative Breast CancerCompletedNCT02996825Phase 1
- Preoperative Chemoradiotherapy With Raltitrexed for Intermediate or Locally Advanced Rectal Cancer in the Fit ElderlyCompletedNCT02992886Phase 2
- Allopurinol in Prevention of Post-Endoscopic Retrograde Cholangiopancreatography PancreatitisCompletedNCT02992652Not applicable
- Varlitinib in Combination With Gemcitabine and Cisplatin for Treatment naïve Advanced or Metastatic BTCTerminatedNCT02992340Phase 1/2
- Gemcitabine in Newly-Diagnosed Diffuse Intrinsic Pontine GliomaCompletedNCT02992015Early Phase 1
- A Phase II Study of Atezolizumab in Combination With Cisplatin + Gemcitabine Before Surgery to Remove the Bladder CancerActive, not recruitingNCT02989584Phase 1/2
- Phase II Study of HAIC Using Cisplatin,Leucovorin and 5-FluorouracilStatus unknownNCT02987699Phase 2
- Decitabine in Combination With Low-dose Cytarabine in Elderly Patients With Acute Myeloid LeukemiaStatus unknownNCT02985372Phase 3
- Role of Neo-adjuvant Chemotherapy in Tongue Preservation in Locally Advanced Squamous Cell Carcinoma of Oral TongueStatus unknownNCT02985255Phase 2
- A Study of Azacitidine in Myelodysplastic Syndrome (MDS) Associated to Systemic Auto-immune and Inflammatory DisordersCompletedNCT02985190Phase 2
- Therapy of Non-Hodgkin-Lymphoma by Combination of Lenalidomide + Rituximab, Dexa, High-dose ARA-C and CisPTerminatedNCT02983097Phase 1/2
- Takayasu Arteritis Clinical Trial in ChinaCompletedNCT02981979Not applicable
- Pemetrexed and Platinum Use in the Neoadjuvant Setting for Resectable Stage II and IIIA Lung Adenocarcinoma (ECTOP-1002)CompletedNCT02980991Phase 2
- Neoadjuvant Chemo-endocrine Therapy Versus Chemotherapy Alone in ER-positive, HER2-negative Breast CancerCompletedNCT02980965Phase 3
- Comparison FOLFIRINOX Panitumumab vs mFOLFOX6 Panitumumab in RAS/B-RAF Wild-type Metastatic Colorectal Cancer PatientsCompletedNCT02980510Phase 2
- Phase II/III Study Comparing Chemoradiotherapy With Radiotherapy in Elderly Patients With Esophageal or Esophagogastric Cancer - 3JECROG P-01CompletedNCT02979691Phase 2/3
- Adjuvant Chemotherapy In Elderly With Colon Cancer Stage IIICompletedNCT02978612Phase 2
- Efficacy and Safety of TPF Induction Chemotherapy for Borderline-resectable Esophageal Squamous Cell CarcinomaCompletedNCT02976909Phase 2
- Evaluation of Hepatic Arterial Infusion of Cisplatin and 5-FU in Biomarker Stratified HCCStatus unknownNCT02967887Phase 2
- A Study Evaluating Venetoclax Alone and in Combination With Azacitidine in Participants With Relapsed/Refractory Myelodysplastic Syndromes (MDS)CompletedNCT02966782Phase 1
- Binimetinib in Addition to Standard Chemotherapy in KRAS Mutated NSCLC.CompletedNCT02964689Phase 1
- Panobinostat Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant for Patients With Refractory/Relapsed LymphomaWithdrawnNCT02961816Phase 2
- Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic MalignanciesCompletedNCT02960646Phase 1
- Decitabine and Gemcitabine for Pancreatic Cancer and SarcomaCompletedNCT02959164Phase 1
- Single-agent Capecitabine as Adjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal CarcinomaStatus unknownNCT02958111Phase 3
- Prevention of Retinal Non-perfusion in Central Retinal Vein Occlusion by Hydroxycarbamide Treatment.Status unknownNCT02957760Phase 2
- Cervical Cancer Radiotherapy by Use of VMAT, Individualized Polyradiosensitization and Interstitial BrachytherapyStatus unknownNCT02957266Phase 3
- An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of RuxolitinibActive, not recruitingNCT02955940Phase 2
- Decitabine Plus R-CHOP in Diffuse Large B-cell LymphomaStatus unknownNCT02951728Phase 1/2
- Neoadjuvant Chemotherapy With SEEOX Regimen for Borrmann Type 4 Gastric CancerStatus unknownNCT02949258Phase 2
- Combination of Platinum Doublets and Hypofractionated Radiotherapy in NSCLCWithdrawnNCT02947113Phase 2
- S1 Plus Docetaxel Versus Capecitabine Plus Docetaxel First-line Treatment in Patients With Advanced Breast CancerStatus unknownNCT02947061Phase 2
- Nimotuzumab Plus S1 Versus Placebo Plus S1 as Maintenance Treatment in Patients With Unresectable Pancreatic CancerStatus unknownNCT02945267Phase 4
- Gemcitabine Hydrochloride, Cisplatin, and AGS-003-BLD in Treating Patients With Muscle-Invasive Bladder Cancer Undergoing SurgeryWithdrawnNCT02944357Not applicable
- Safety of TAS-102 in Combination With Temozolomide for Metastatic Pancreatic NETsTerminatedNCT02943733Phase 1
- Low-dose AZA, Pioglitazone, ATRA Versus Standard-dose AZA in Patients >=60 Years With Refractory AMLTerminatedNCT02942758Phase 2
- A Study Evaluating Venetoclax in Combination With Azacitidine in Participants With Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)CompletedNCT02942290Phase 1
- A Study of Gemcitabine-Carboplatin Plus Necitumumab (LY3012211) in Chemotherapy-Naïve Participants With Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)WithdrawnNCT02941601Phase 2
- BE Study in Patients - Methotrexate TabletsStatus unknownNCT02940561Phase 1
- Infusion of 5-Azacytidine (5-AZA) Into the Fourth Ventricle in Children With Recurrent Posterior Fossa EpendymomaCompletedNCT02940483Early Phase 1
- Pilot Study of Autologous Chimeric Switch Receptor Modified T Cells in Recurrent Glioblastoma MultiformeStatus unknownNCT02937844Phase 1
- Efficacy of Idarubicin, Cytarabine and Cyclophosphamide (IAC) Regimen in Relapsed/Refractory AMLCompletedNCT02937662Phase 2
- Capecitabine and Lenvatinib With External Radiation in Rectal AdenocarcinomaCompletedNCT02935309Phase 1
- Metastatic Colorectal Cancer (RAS-wildtype) After Response to First-line Treatment With FOLFIR Plus CetuximabCompletedNCT02934529Phase 3
- CD19-redirected Autologous Cells (CAR-CD19 T Cells)Status unknownNCT02933775Phase 1
- D-Cycloserine and Virtual Reality Exposure TherapyWithdrawnNCT02933684Phase 2
- Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Patients With Pediatric Solid Tumors (GAP)Active, not recruitingNCT02932956Phase 1
- Multicentric Randomised Trial for Resectable Gastric CancerActive, not recruitingNCT02931890Phase 2
- Fludarabine and Cytarabine Versus High-dose Cytarabine for CBF-AMLCompletedNCT02926586Phase 4
- Concurrent Chemotherapy Based on Genetic Testing in Patients With High-Risk Salivary Gland TumorsCompletedNCT02921984Phase 1